Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription 07.08.2023 6 Antiviral Res 1 Biochem Biophys Res Commun 1 BMC Pediatr 1 J Infect 1 J Infect Dis 2 JAMA 4 Lancet 1 N Engl J Med 2 Pediatrics 1 PLoS Biol 2 PLoS Comput Biol 1 PLoS Med 32 PLoS One 2 Proc Natl Acad Sci U S A 18 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. TAKASHITA E, Fujisaki S, Morita H, Nagata S, et al
   Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors.
   Antiviral Res. 2023;216:105671.
   PubMed         Abstract available
   
   
2. JEONG JH, Choi JH, Kim BK, Min SC, et al
   Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronaviruses.
   Antiviral Res. 2023 Jul 10:105669. doi: 10.1016/j.antiviral.2023.105669.
   PubMed         Abstract available
   
   
3. CAI H, Yan J, Liu S, Li P, et al
   Paxlovid for hospitalized COVID-19 patients with chronic kidney disease.
   Antiviral Res. 2023 Jun 25:105659. doi: 10.1016/j.antiviral.2023.105659.
   PubMed         Abstract available
   
   
4. MILAN BONOTTO R, Mitrovic A, Sosic I, Martinez-Orellana P, et al
   Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection.
   Antiviral Res. 2023;216:105655.
   PubMed         Abstract available
   
   
5. JUNG HE, Ku KB, Kang BH, Park JH, et al
   Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
   Antiviral Res. 2023;216:105656.
   PubMed         Abstract available
   
   
6. CHANG YJ, Le UNP, Liu JJ, Li SR, et al
   Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV.
   Antiviral Res. 2023 Jun 13:105653. doi: 10.1016/j.antiviral.2023.105653.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

7. FUJISAWA M, Adachi Y, Onodera T, Shiwa-Sudo N, et al
   High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
   Biochem Biophys Res Commun. 2023;673:114-120.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

8. SARBAKHSH P, Jafari N, Salemi S, Akbarnejad R, et al
   Predictors of Pediatric COVID-19 vaccination: a case-control study in Tabriz, Iran.
   BMC Pediatr. 2023;23:379.
   PubMed         Abstract available
   
   

   
   J Infect

9. YAO XY, Lian CY, Lv ZH, Zhang XL, et al
   Emergence of a novel reassortant H5N6 subtype highly pathogenic avian influenza virus in farmed dogs in China.
   J Infect. 2023 Jul 26:S0163-4453(23)00386-9. doi: 10.1016/j.jinf.2023.
   PubMed        
   
   

   
   J Infect Dis

10. COHEN LE, Hansen CL, Andrew MK, McNeil SA, et al
    Predictors of severity of influenza-related hospitalizations: Results from the Global Influenza Hospital Surveillance Network (GIHSN).
    J Infect Dis. 2023 Aug 1:jiad303. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    JAMA

11. DAVIDSON BL, Levi MM
    Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    JAMA. 2023;330:471-472.
    PubMed        
    
    
12. GOLIGHER EC, Lawler PR, Zarychanski R
    Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
    JAMA. 2023;330:472-473.
    PubMed        
    
    

    
    Lancet

13. HSU NC, Hsu CH
    COVID-19 and commerce complicate minimum unit pricing effects on health.
    Lancet. 2023;402:368.
    PubMed        
    
    
14. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
    COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
    Lancet. 2023;402:368-369.
    PubMed        
    
    
15. 
    The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    PubMed         Abstract available
    
    
16. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    PubMed         Abstract available
    
    

    
    N Engl J Med

17. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    PubMed        
    
    

    
    Pediatrics

18. ATWELL JE, Hartman RM, Parker D, Taylor K, et al
    RSV Among American Indian and Alaska Native Children: 2019 to 2020.
    Pediatrics. 2023;152:e2022060435.
    PubMed        
    
    
19. JIANG L, Li X, Nie J, Tang K, et al
    A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population.
    Pediatrics. 2023;152:e2022060351.
    PubMed         Abstract available
    
    

    
    PLoS Biol

20. LADNER JT, Sahl JW
    Towards a post-pandemic future for global pathogen genome sequencing.
    PLoS Biol. 2023;21:e3002225.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

21. YANG W, Shaman J
    Development of Accurate Long-lead COVID-19 Forecast.
    PLoS Comput Biol. 2023;19:e1011278.
    PubMed         Abstract available
    
    
22. PARAG KV, Obolski U
    Risk averse reproduction numbers improve resurgence detection.
    PLoS Comput Biol. 2023;19:e1011332.
    PubMed         Abstract available
    
    

    
    PLoS Med

23. ANTILLON M, Li X, Willem L, Bilcke J, et al
    The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach.
    PLoS Med. 2023;20:e1004250.
    PubMed         Abstract available
    
    

    
    PLoS One

24. QIU L, Li C, He W, Yin X, et al
    Changes in diet, exercise and psychology of the quarantined population during the COVID-19 outbreak in Shanghai.
    PLoS One. 2023;18:e0284799.
    PubMed         Abstract available
    
    
25. WINN PZ, Hlaing T, Tun KM, Lei SL, et al
    Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.
    PLoS One. 2023;18:e0288285.
    PubMed         Abstract available
    
    
26. LAVELL AHA, Tijdink J, Buis DTP, Smulders YM, et al
    Why not to pick your nose: Association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers.
    PLoS One. 2023;18:e0288352.
    PubMed         Abstract available
    
    
27. DOREMUS J, Li L, Jones D
    Covid-related surge in global wild bird feeding: Implications for biodiversity and human-nature interaction.
    PLoS One. 2023;18:e0287116.
    PubMed         Abstract available
    
    
28. PARMLEY LE, Nkumbula T, Chilukutu L, Chelu L, et al
    Impacts of COVID-19 on sexual risk behaviors, safe injection practices, and access to HIV services among key populations in Zambia: Findings from a rapid qualitative formative assessment.
    PLoS One. 2023;18:e0289007.
    PubMed         Abstract available
    
    
29. LANDE J, Pillay A, Chandra R
    Deep learning for COVID-19 topic modelling via Twitter: Alpha, Delta and Omicron.
    PLoS One. 2023;18:e0288681.
    PubMed         Abstract available
    
    
30. PHU DH, Maneerattanasak S, Shohaimi S, Trang LTT, et al
    Prevalence and factors associated with long COVID and mental health status among recovered COVID-19 patients in southern Thailand.
    PLoS One. 2023;18:e0289382.
    PubMed         Abstract available
    
    
31. SORRELL L, Leta V, Barnett A, Stevens K, et al
    Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
    PLoS One. 2023;18:e0285349.
    PubMed         Abstract available
    
    
32. VAN DEN BOOM W, van Dijk M, Snijders B, Luijben G, et al
    Cohort profile: The Corona Behavioral Unit cohort, a longitudinal mixed-methods study on COVID-19-related behavior, well-being and policy support in the Netherlands.
    PLoS One. 2023;18:e0289294.
    PubMed         Abstract available
    
    
33. KIM E, Cho T, Koo B, Kang HG, et al
    Conditional autoencoder asset pricing models for the Korean stock market.
    PLoS One. 2023;18:e0281783.
    PubMed         Abstract available
    
    
34. KIGONGO E, Kabunga A, Tumwesigye R, Musinguzi M, et al
    Prevalence and predictors of COVID-19 vaccination hesitancy among healthcare workers in Sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0289295.
    PubMed         Abstract available
    
    
35. AHMED OB, Asghar AH, Bamaga M, Bahwerth FS, et al
    Characterization of aminoglycoside resistance genes in multidrug-resistant Klebsiella pneumoniae collected from tertiary hospitals during the COVID-19 pandemic.
    PLoS One. 2023;18:e0289359.
    PubMed         Abstract available
    
    
36. PILONE V, di Santo N, Sisto R
    Factors affecting food waste: A bibliometric review on the household behaviors.
    PLoS One. 2023;18:e0289323.
    PubMed         Abstract available
    
    
37. YAMAMOTO T, Sugimoto K, Ichikawa S, Suzuki K, et al
    Impact of body composition on patient prognosis after SARS-Cov-2 infection.
    PLoS One. 2023;18:e0289206.
    PubMed         Abstract available
    
    
38. MUKOKA M, Sibanda E, Watadzaushe C, Kumwenda M, et al
    COVID-19 self-testing using antigen rapid diagnostic tests: Feasibility evaluation among health-care workers and general population in Malawi.
    PLoS One. 2023;18:e0289291.
    PubMed         Abstract available
    
    
39. YU Z, Wang J, Tan Z, Luo Y, et al
    Impact of climate change on SARS-CoV-2 epidemic in China.
    PLoS One. 2023;18:e0285179.
    PubMed         Abstract available
    
    
40. BIZRI AR, El-Fattah AA, Bazaraa HM, Al Ramahi JW, et al
    Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
    PLoS One. 2023;18:e0288550.
    PubMed         Abstract available
    
    
41. BRIERE O, Otekpo M, Asfar M, Gautier J, et al
    Initial functional disability as a 1-year prognostic factor in geriatric patients hospitalized with SARS-CoV-2 infection.
    PLoS One. 2023;18:e0289297.
    PubMed         Abstract available
    
    
42. WULLSCHLEGER A, Goncalves L, Royston M, Sentissi O, et al
    Admissions to psychiatric inpatient services and use of coercive measures in 2020 in a Swiss psychiatric department: An interrupted time-series analysis.
    PLoS One. 2023;18:e0289310.
    PubMed         Abstract available
    
    
43. YAACOUB S, Chamseddine F, Jaber F, Blazic I, et al
    Exploring the concordance of recommendations across guidelines on chest imaging for the diagnosis and management of COVID-19: A proposed methodological approach based on a case study.
    PLoS One. 2023;18:e0288359.
    PubMed         Abstract available
    
    
44. KIM SJ, Aye YM, Panyarachun D, Hong SA, et al
    Social support for postpartum women and associated factors including online support to reduce stress and depression amidst COVID-19: Results of an online survey in Thailand.
    PLoS One. 2023;18:e0289250.
    PubMed         Abstract available
    
    
45. ZHANG Y, Luo A, Hou L, Chen S, et al
    Crisis response during the COVID-19 pandemic: Changes in social contact and social participation of older Americans.
    PLoS One. 2023;18:e0284935.
    PubMed         Abstract available
    
    
46. ARCHER J, Mikelonis A, Wyrzykowska-Ceradini B, Morris E, et al
    Evaluation of disinfection methods for personal protective equipment (PPE) items for reuse during a pandemic.
    PLoS One. 2023;18:e0287664.
    PubMed         Abstract available
    
    
47. MOORE JB, Rubin KCR, Heaney CA
    Benefit finding and well-being over the course of the COVID-19 pandemic.
    PLoS One. 2023;18:e0288332.
    PubMed         Abstract available
    
    
48. XIE Z, Qalati SA, Limon MLS, Sulaiman MABA, et al
    Understanding factors influencing healthcare workers' intention towards the COVID-19 vaccine.
    PLoS One. 2023;18:e0286794.
    PubMed         Abstract available
    
    
49. FINK G, Fortsch K, Felder S
    Subjective burden of government-imposed Covid-19 restrictions in Switzerland: Evidence from the 2022 LINK Covid-19 survey.
    PLoS One. 2023;18:e0283524.
    PubMed         Abstract available
    
    
50. WASHBURN C, Kantsiper ME, Esteve R, Gupta I, et al
    Comparison of hospitalist morale in a COVID-19 alternate care site (ACS) to hospitalist morale in conventional hospitals in Maryland.
    PLoS One. 2023;18:e0288981.
    PubMed         Abstract available
    
    
51. BALATE D, Afai G, Salle F, Simone T, et al
    Mask use in public places in Maputo City, Mozambique: Cross-sectional survey.
    PLoS One. 2023;18:e0288957.
    PubMed         Abstract available
    
    
52. LARCOMBE L, Ringaert L, Restall G, McLeod A, et al
    "Because of COVID...": The impacts of COVID-19 on First Nation people accessing the HIV cascade of care in Manitoba, Canada.
    PLoS One. 2023;18:e0288984.
    PubMed         Abstract available
    
    
53. CASTELLANOS-TORRES E, Sanz-Barbero B, Vives-Cases C
    COVID-19 and sexual violence against women: A qualitative study about young people and professionals' perspectives in Spain.
    PLoS One. 2023;18:e0289402.
    PubMed         Abstract available
    
    
54. KOWATSCH MM, Lajoie J, Mwangi L, Omollo K, et al
    Hydroxychloroquine reduces T cells activation recall antigen responses.
    PLoS One. 2023;18:e0287738.
    PubMed         Abstract available
    
    
55. COULAUD PJ, Jesson J, Bolduc N, Ferlatte O, et al
    Association between level of compliance with COVID-19 public health measures and depressive symptoms: A cross-sectional survey of young adults in Canada and France.
    PLoS One. 2023;18:e0289547.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

56. BILINSKI AM, Salomon JA, Hatfield LA
    Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations.
    Proc Natl Acad Sci U S A. 2023;120:e2302528120.
    PubMed         Abstract available
    
    
57. BADER SM, Cooney JP, Sheerin D, Taiaroa G, et al
    SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.
    Proc Natl Acad Sci U S A. 2023;120:e2301689120.
    PubMed         Abstract available
    
    

    
    Vaccine

58. CHAUDHARY A, Madhavan R, Babji S, Raju R, et al
    Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
    Vaccine. 2023 Jun 23:S0264-410X(23)00744-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
59. HOWARD MC
    Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates and vaccination outcomes.
    Vaccine. 2023 Jun 23:S0264-410X(23)00742-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
60. LUANGASANATIP N, Painter C, Pan-Ngum W, Saralamba S, et al
    How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic.
    Vaccine. 2023 Jun 20:S0264-410X(23)00740-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
61. SALEH SN, McDonald SA, Basit MA, Kumar S, et al
    Public perception of COVID-19 vaccines through analysis of Twitter content and users.
    Vaccine. 2023 Jun 23:S0264-410X(23)00743-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
62. TURLEY CB, Tables L, Fuller T, Sanders LJ, et al
    Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
    Vaccine. 2023 Jun 23:S0264-410X(23)00755-7. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
63. SHENG Y, Li Z, Lin X, Ma Y, et al
    The position of Spy Tag/Catcher system in hepatitis B core protein particles affects the immunogenicity and stability of the synthetic vaccine.
    Vaccine. 2023 Jun 28:S0264-410X(23)00759-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
64. TORP HANSEN K, Kusk Povlsen F, Hammer Bech B, Nygaard Hansen S, et al
    Immediate adverse reactions following COVID-19 vaccination among 16-65-year-old Danish citizens.
    Vaccine. 2023 Jun 23:S0264-410X(23)00758-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
65. HONDA-OKUBO Y, Sakala IG, Andre G, Tarbet EB, et al
    An Advax-CpG55.2 adjuvanted recombinant hemagglutinin vaccine provides immunity against H7N9 influenza in adult and neonatal mice.
    Vaccine. 2023 Jul 31:S0264-410X(23)00892-7. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
66. MO J, Spackman E, Swayne DE
    Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review.
    Vaccine. 2023 Aug 1:S0264-410X(23)00922-2. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
67. KIM DH, Lee J, Youk S, Jeong JH, et al
    Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection.
    Vaccine. 2023;41:4787-4797.
    PubMed         Abstract available
    
    
68. DUNN DT, Gilson R, McCormack S, McCoy LE, et al
    Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials.
    Vaccine. 2023 Jun 16:S0264-410X(23)00712-0. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
69. MADRAN B, Kayi I, Beser A, Ergonul O, et al
    Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study.
    Vaccine. 2023 Jun 9:S0264-410X(23)00688-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
70. MASOUD D, Pierz A, Rauh L, Cruz AK, et al
    Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust.
    Vaccine. 2023 Jun 17:S0264-410X(23)00690-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
71. PUTHANAKIT T, Chokephaibulkit K, Chaithongwongwatthana S, Bhat N, et al
    A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
    Vaccine. 2023 Jun 15:S0264-410X(23)00657-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
72. BEYERS KCL, Rbeihat MNM, S Vasconcelos D, Pasmans D, et al
    Preclinical evaluation of performance, safety and usability of VAX-ID(R), a novel intradermal injection device.
    Vaccine. 2023;41:4609-4615.
    PubMed         Abstract available
    
    
73. KOZMA GT, Meszaros T, Berenyi P, Facsko R, et al
    Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.
    Vaccine. 2023 Jun 5:S0264-410X(23)00667-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
74. DE GIER B, van Asten L, Boere TM, van Roon A, et al
    Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021-January 2022.
    Vaccine. 2023 Jun 8:S0264-410X(23)00660-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
75. UI M, Hirama T, Akiba M, Honda M, et al
    Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan.
    Vaccine. 2023 Jun 9:S0264-410X(23)00663-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    

    
    Virology

76. ZHOU H, Liu J, Li L, Sun J, et al
    Circulation of influenza C virus of C/Sao Paulo/378/82 lineage among pediatric acute respiratory cases, Shandong, China.
    Virology. 2023;587:109855.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: